A fatty liver is exactly what it sounds like: a liver that has accumulated too much fat. A healthy liver contains some fat, but when fat makes up more than 5% to 10% of the organ’s weight, it crosses into disease territory. Around 1.3 billion people worldwide, roughly 16% of the global population, are living with this condition, making it one of the most common liver problems on the planet.
You might see this condition referred to by different names. For decades, doctors called it nonalcoholic fatty liver disease (NAFLD) when alcohol wasn’t the primary driver. In 2023, the medical community officially renamed it metabolic dysfunction-associated steatotic liver disease, or MASLD, to better reflect what actually causes it. The more severe, inflammatory form, previously called NASH, is now called MASH. You’ll still see the old names everywhere, but they describe the same conditions.
How Fat Builds Up in the Liver
Your liver constantly processes fats, packaging them up and sending them out to the rest of the body. Fatty liver develops when that balance tips: more fat flowing in than the liver can burn or export. Three things can go wrong at once. The liver takes in too many fatty acids from the bloodstream, it ramps up its own internal fat production, and its ability to burn fat or ship it out declines. When all three happen together, fat droplets accumulate inside liver cells.
The single biggest metabolic driver is insulin resistance. When your body’s fat tissue stops responding properly to insulin, it begins releasing a flood of fatty acids into the bloodstream. This overflow accounts for roughly 60% of the fat that ends up stored in the liver. At the same time, insulin resistance triggers the liver to produce even more fat on its own through a process called de novo lipogenesis, essentially converting sugars into fat. The combination overwhelms the liver’s capacity to keep up.
The Role of Diet, Especially Sugar
Not all dietary sugars affect the liver equally. Fructose is a notably potent driver of liver fat production because of the way the liver processes it. The liver breaks down fructose about ten times faster than it breaks down glucose, and much of that fructose gets converted directly into fat. Both human and animal studies confirm that fructose is a stronger trigger for liver fat production than glucose, largely because the liver is the primary organ responsible for metabolizing it.
This doesn’t mean fruit is the problem. The fructose loads that cause trouble come mainly from sugary drinks, processed foods with added sugars, and high-fructose corn syrup. When fructose arrives in large amounts, the liver’s fat-making machinery ramps up, and at the same time, fat burning slows down. That one-two punch accelerates fat accumulation.
Beyond fructose, diets high in refined carbohydrates and saturated fats contribute through the same general pathway: more raw material for the liver to convert into stored fat, paired with metabolic signals that suppress the liver’s ability to clear it.
Who Gets Fatty Liver
The formal diagnosis of MASLD requires both liver fat and at least one of five metabolic risk factors: being overweight or obese, having elevated blood sugar or type 2 diabetes, high blood pressure, high triglycerides, or low HDL (“good”) cholesterol. In practice, most people with fatty liver check more than one of those boxes.
Men are affected at slightly higher rates than women globally. Prevalence varies dramatically by region. North Africa and the Middle East have the highest rates, nearly double the global average, while high-income Asia Pacific countries have the lowest. These differences reflect a mix of dietary patterns, obesity rates, and genetic factors across populations.
Genetics also play a measurable role. A well-studied variant of the PNPLA3 gene, carried by a significant portion of the population, produces a less effective version of an enzyme that helps break down fat in liver cells. People who carry this variant accumulate liver fat more easily and face a higher risk of progressing to inflammation, scarring, and even liver cancer. This helps explain why some people develop fatty liver at lower body weights or with fewer obvious risk factors than others.
When Simple Fat Becomes Something Worse
Simple fat accumulation in the liver, called steatosis, is the earliest and most reversible stage. Many people stay at this stage for years or even decades without serious consequences. The concern is progression to MASH, where inflammation and liver cell damage join the picture.
This transition happens when certain types of fat become toxic to liver cells. Saturated fatty acids, free cholesterol, and specific fat-derived molecules accumulate and start damaging cells directly. Cholesterol buildup makes liver cells more vulnerable to dying, and when they do, they release distress signals that recruit immune cells from the bone marrow. These immune cells ramp up inflammation, and the inflammation in turn activates a third type of cell, stellate cells, which begin producing scar tissue.
What makes this dangerous is the feedback loop it creates. Damaged liver cells attract immune cells, which drive more inflammation, which activates more scarring, which damages more liver cells. The liver’s ability to burn fat also declines as the disease advances, accelerating fat accumulation further. Over time, this cycle can lead to significant scarring (fibrosis), and eventually cirrhosis, where the liver’s structure is permanently altered.
How Fatty Liver Is Detected
Fatty liver rarely causes noticeable symptoms in its early stages. Most people find out about it incidentally, during imaging or blood work done for another reason.
Standard abdominal ultrasound is the most common screening tool because it’s inexpensive and widely available. It picks up moderate to severe fat accumulation with sensitivity ranging from 60% to 95%, but it’s much less reliable when fat affects fewer than 30% of liver cells. In other words, ultrasound can miss mild cases.
Elastography, a newer imaging technique that measures liver stiffness, performs significantly better. In studies of patients with diabetes and metabolic syndrome, elastography detected fatty liver and fibrosis with 100% sensitivity compared to 82.5% for standard ultrasound, and it was far more specific, correctly ruling out disease 86% of the time versus just 32% for ultrasound. This matters most for catching early fibrosis, which standard ultrasound often cannot detect at all.
What Causes It to Reverse
The encouraging reality about fatty liver is that the early stages are highly reversible. Because excess calorie intake and insulin resistance are the primary drivers, weight loss is the most effective intervention. Losing roughly 5% to 7% of body weight can meaningfully reduce liver fat, and losing 10% or more can begin to reverse fibrosis in some cases.
The specific approach to weight loss matters less than the outcome. Reducing sugar-sweetened beverages, cutting back on refined carbohydrates, and increasing physical activity all target the underlying metabolic dysfunction. Exercise improves insulin sensitivity independently of weight loss, which helps slow the flood of fatty acids from fat tissue to the liver. Even modest increases in physical activity, such as regular brisk walking, have measurable effects on liver fat.
Alcohol, even in moderate amounts, adds an additional burden. People who have metabolic fatty liver and also drink regularly fall into an overlap category (called MetALD) that carries higher risk than either condition alone. Reducing or eliminating alcohol removes one source of liver stress that compounds all the metabolic factors already at work.